The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Non-Replicating mRNA
- In Vivo Self-Replicating mRNA
- In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
- Others
Segment by Application
- Hospitals
- Vaccination Center
- Specialized Clinics
- Hospital Pharmacy
- Others
By Region
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
By Company
- Sanofi Pasteur Inc.
- AstraZeneca
- CSL Ltd.
- Abbott
- GlaxoSmithKline Plc.
- Serum Institute of India Pvt. Ltd.
- Pfizer
- BioNTech
- F.Hoffman La Roche Ltd
- Novartis
- Sinnovac Biotech Ltd
- Moderna Therapeutics
- CureVac
